The Beacon Study is seeking volunteers to test an enlightening at-home investigational device. We’re looking at how safe the investigational device is and how well it may work to speed recovery in people with COVID-19.
This study is evaluating the safety and immune response generated by an investigational bivalent COVID-19 vaccine as a primary 3-dose series plus booster in healthy infants and children under 5 who have not previously been vaccinated for COVID-19.
This clinical study will allow researchers to learn about an investigational study vaccine to see if it may help protect against pneumococcal disease in adults at increased risk of pneumococcal infection due to stable chronic conditions.
Worldwide, ATRIAL FIBRILLATION is one of the most common causes of stroke. Researchers are now exploring the use of an investigational drug in patients with atrial fibrillation.
The SURMOUNT-MMO Study is evaluating the effectiveness of an investigational medication (trial treatment) on reducing health risks that are commonly found in people who are living with obesity or are overweight. This clinical trial is focusing particularly on cardiovascular (heart) disease and other heart health risks.
If you or a loved one has started feeling sick with COVID-19 in the past 5 days, please contact our study team to see if you qualify.
If you care for someone who may have a diagnosis of Alzheimer’s disease and they have been experiencing symptoms of disruptive behavior which have made caring for them even more difficult, the ADVANCE-2 study may be an option.
Pneumococcal disease is an illness caused by certain germs (bacteria), called Streptococcus pneumoniae. These germs can cause serious infections in the ears, nose, lungs, blood, or brain. Vaccines help the body fight infections due to diseases like pneumococcal disease, and may help prevent serious illness. New vaccines must be tested to show that they work.
Participation in a clinical trial is 100% voluntary and at your discretion. There is no cost to participate and you may be compensated for study related travel. Investigational medications will be provided at no cost.
You may qualify if you have a type of heart failure where your heart has less strength than normal to pump blood to your body, and if you have not recently been hospitalized for your heart failure or experienced a worsening of your heart failure that required urgent treatment.
Providing a community-based service and reliable data making possible the advances in the field of Investigational Research for new and better drugs.
Working Hours
Monday — Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)